Murphy Keith 4
4 · VivoSim Labs, INC. · Filed Jan 29, 2026
Research Summary
AI-generated summary of this filing
VivoSim (VIVS) Exec Chairman Murphy Keith Receives 15,000 RSU Award
What Happened Murphy Keith, Executive Chairman and director of VivoSim Labs, was granted 15,000 restricted stock units (RSUs) on January 27, 2026. The reported acquisition price is $0.00 (a compensation award), so no cash was paid by the insider. This is a grant of equity compensation, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-01-27; Form 4 filed 2026-01-29 (timely within the standard 2-business-day window).
- Transaction type/code: Award/Grant (A); 15,000 shares @ $0.00 (acquired).
- Shares owned after transaction: Not specified in the filing.
- Footnote F1: RSUs vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders; vesting may accelerate on a change of control.
- Footnote F2: All share counts reflect a 1-for-12 reverse stock split effective March 20, 2025.
- Remarks: Exhibit 24 (Power of Attorney) attached to the filing.
Context RSU grants are a form of compensation and typically vest over time or upon corporate events; they do not represent an immediate cash outlay or an open-market bet by the insider. The economic value of these units depends on VivoSim’s future stock price and the vesting conditions described in the footnote.
Insider Transaction Report
Form 4
Murphy Keith
DirectorEXECUTIVE CHAIRMAN
Transactions
- Award
Common Stock
[F1][F2]2026-01-27+15,000→ 26,053 total
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units, which shall vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control.
- [F2]Effective on March 20, 2025, the Issuer conducted a reverse stock split of its common stock at a ratio of 1-for-12 (the "Reverse Split"). All share numbers reported herein give effect to the Reverse Split.
Signature
/s/ Norman Staskey, attorney-in-fact|2026-01-29